SID142

DRUG2 trials

Sponsors

SK Chemicals Co., Ltd.

Conditions

Arterial Occlusive DiseasesPeripheral Arterial Disease

Phase 1

Safety/Tolerability and Pharmacokinetic Study of SID142

CompletedNCT02625714

SK Chemicals Co., Ltd.Arterial Occlusive Diseases

Start: 2015-06-30End: 2015-07-31Updated: 2015-12-14

Phase 3

Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease

CompletedNCT03318276

SK Chemicals Co., Ltd.Peripheral Arterial Disease

Start: 2017-02-20End: 2018-10-15Updated: 2019-09-20

Related Papers

An Integrated Study of the South-Central Part of the Springerville Volcanic Field; The Final Piece

Clinical Therapeutics2023-08-151 citations

Efficacy and Safety of SID142 in Patients With Peripheral Arterial Disease: A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group, Phase III Clinical Trial.

2022-04-092 citations